Gestational trophoblastic disease (GTD) is a relatively rare but important group of benign and malignant disorders that affect women of child-bearing potential. Most cases are now diagnosed ...
Gestational trophoblastic disease (GTD) is a rare group of tumors that develop early in pregnancy. It occurs when abnormal cells grow in the "trophoblastic" tissue which typically surrounds the ...
Gestational trophoblastic diseases (GTD) are conditions that occur following conception. They result from faulty placental cells. Like healthy pregnancy tissues these grow rapidly, but unfortunately ...
Low-risk patients with gestational trophoblastic disease (GTD) are initially treated with methotrexate (MTX)/folinic acid (FA) as this regimen is well tolerated and has no long-term sequelae.
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
Dostarlimab is under clinical development by GSK and currently in Phase II for Vulvar Cancer. According to GlobalData, Phase II drugs for Vulvar Cancer have a 13% phase transition success rate (PTSR) ...